In the E0771-LG metastatic breast cancer model, a CCR1 ligand, CCL3, is expressed by MAMs at higher level than other types of tumor-infiltrating immune cells or circulating monocytes, and loss of Ccl3 reduces MAM accumulation in the metastatic lung. This evidence concerns the gene CCR1 and breast carcinoma.